News Headlines Article

Gilead HIV drug recommended by CDC to prevent AIDS virus
San Francisco Business Times

People at high risk of contracting HIV should pop Gilead Sciences Inc.’s Truvada pill once a day to decrease their chances of contracting the AIDS virus, the Centers for Disease Control and Prevention said Wednesday.

Truvada was approved in July 2012 by the Food and Drug Administration as the first drug to prevent HIV infection in combination with safe sex and regular testing. But the CDC’s announcement is one of the first formal government endorsements of the Foster City-based company’s drug as part of a strategy known as PrEP, or pre-exposure prophylaxis.